Resistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma.

Adhikaree, Jason; Moreno-Vicente, Julia; Kaur, Aanchal Preet; Jackson, Andrew Mark; Patel, Poulam M

Adhikaree, Jason; Moreno-Vicente, Julia; Kaur, Aanchal Preet; Jackson, Andrew Mark; Patel, Poulam M.

Afiliação

Adhikaree J; Host-Tumour Interactions Group, Division of Cancer and Stem Cells, BioDiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.
Moreno-Vicente J; Antibody and Vaccine Group, Centre for Cancer Immunology, University of Southampton, Southampton General Hospital, Southampton, Hants, SO16 6YD, UK.
Kaur AP; Host-Tumour Interactions Group, Division of Cancer and Stem Cells, BioDiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.
Jackson AM; Host-Tumour Interactions Group, Division of Cancer and Stem Cells, BioDiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.
Patel PM; Host-Tumour Interactions Group, Division of Cancer and Stem Cells, BioDiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK.

Cells ; 9(2)2020 01 21.

Article em En | MEDLINE | ID: mdl-31973059

Assuntos

Resistencia a Medicamentos Antineoplásicos; Glioblastoma/imunologia; Glioblastoma/terapia; Imunoterapia; Humanos; Terapia de Alvo Molecular; Transdução de Sinais; Microambiente Tumoral/imunologia

Palavras-chave

glioblastoma; immune checkpoint blockade; immunotherapy; programme death-1; resistance mechanisms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Resistencia a Medicamentos Antineoplásicos / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google